Potravitug

PARIS, France & SCHLIEREN/ZURICH, Switzerland, July 1, 2026 Ipsen has announced a definitive agreement to acquire Memo Therapeutics AG,...

SCHLIEREN / ZURICH, Switzerland, June 5, 2026 Memo Therapeutics AG announced additional positive analyses from its Phase II SAFE...